# Application of UCPCR as a Testing Tool for Identification of MODY Patients in the UAE

> **NCT03607604** · — · UNKNOWN · sponsor: **Imperial College London Diabetes Centre** · enrollment: 778 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Maturity-onset Diabetes of the Young

## Interventions

- **GENETIC:** Next generation sequencing (NGS)

## Key facts

- **NCT ID:** NCT03607604
- **Lead sponsor:** Imperial College London Diabetes Centre
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-04-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 778 (ESTIMATED)
- **Last updated:** 2020-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03607604

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03607604, "Application of UCPCR as a Testing Tool for Identification of MODY Patients in the UAE". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03607604. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*